GALT
Price
$1.32
Change
+$0.02 (+1.54%)
Updated
Jun 6 closing price
Capitalization
83.54M
70 days until earnings call
PMN
Price
$0.48
Change
-$0.00 (-0.00%)
Updated
Jun 6 closing price
Capitalization
15.72M
70 days until earnings call
Interact to see
Advertisement

GALT vs PMN

Header iconGALT vs PMN Comparison
Open Charts GALT vs PMNBanner chart's image
Galectin Therapeutics
Price$1.32
Change+$0.02 (+1.54%)
Volume$242.98K
Capitalization83.54M
ProMIS Neurosciences
Price$0.48
Change-$0.00 (-0.00%)
Volume$58K
Capitalization15.72M
GALT vs PMN Comparison Chart
Loading...
GALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GALT vs. PMN commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GALT is a Buy and PMN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (GALT: $1.29 vs. PMN: $0.48)
Brand notoriety: GALT and PMN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GALT: 65% vs. PMN: 110%
Market capitalization -- GALT: $81.65M vs. PMN: $15.72M
GALT [@Biotechnology] is valued at $81.65M. PMN’s [@Biotechnology] market capitalization is $15.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GALT’s FA Score shows that 0 FA rating(s) are green whilePMN’s FA Score has 0 green FA rating(s).

  • GALT’s FA Score: 0 green, 5 red.
  • PMN’s FA Score: 0 green, 5 red.
According to our system of comparison, both GALT and PMN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GALT’s TA Score shows that 3 TA indicator(s) are bullish while PMN’s TA Score has 4 bullish TA indicator(s).

  • GALT’s TA Score: 3 bullish, 5 bearish.
  • PMN’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, PMN is a better buy in the short-term than GALT.

Price Growth

GALT (@Biotechnology) experienced а +0.78% price change this week, while PMN (@Biotechnology) price change was -3.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

GALT is expected to report earnings on Aug 18, 2025.

PMN is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GALT($83.5M) has a higher market cap than PMN($15.7M). GALT YTD gains are higher at: 0.000 vs. PMN (-49.356). PMN has higher annual earnings (EBITDA): -391.76K vs. GALT (-40.38M). GALT has more cash in the bank: 27.1M vs. PMN (21.6M). PMN has less debt than GALT: PMN (4.05M) vs GALT (105M). GALT (0) and PMN (0) have equivalent revenues.
GALTPMNGALT / PMN
Capitalization83.5M15.7M532%
EBITDA-40.38M-391.76K10,307%
Gain YTD0.000-49.356-
P/E RatioN/A5.34-
Revenue00-
Total Cash27.1M21.6M125%
Total Debt105M4.05M2,593%
FUNDAMENTALS RATINGS
GALT vs PMN: Fundamental Ratings
GALT
PMN
OUTLOOK RATING
1..100
813
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
94
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10093
PRICE GROWTH RATING
1..100
8690
P/E GROWTH RATING
1..100
10099
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PMN's Valuation (94) in the null industry is in the same range as GALT (96) in the Biotechnology industry. This means that PMN’s stock grew similarly to GALT’s over the last 12 months.

PMN's Profit vs Risk Rating (100) in the null industry is in the same range as GALT (100) in the Biotechnology industry. This means that PMN’s stock grew similarly to GALT’s over the last 12 months.

PMN's SMR Rating (93) in the null industry is in the same range as GALT (100) in the Biotechnology industry. This means that PMN’s stock grew similarly to GALT’s over the last 12 months.

GALT's Price Growth Rating (86) in the Biotechnology industry is in the same range as PMN (90) in the null industry. This means that GALT’s stock grew similarly to PMN’s over the last 12 months.

PMN's P/E Growth Rating (99) in the null industry is in the same range as GALT (100) in the Biotechnology industry. This means that PMN’s stock grew similarly to GALT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GALTPMN
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 12 days ago
79%
Bullish Trend 12 days ago
80%
Momentum
ODDS (%)
Bearish Trend 12 days ago
86%
Bearish Trend 12 days ago
90%
MACD
ODDS (%)
Bearish Trend 12 days ago
87%
Bullish Trend 12 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
79%
Bearish Trend 12 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
86%
Bearish Trend 12 days ago
90%
Advances
ODDS (%)
Bullish Trend about 1 month ago
79%
Bullish Trend 13 days ago
82%
Declines
ODDS (%)
Bearish Trend 19 days ago
85%
Bearish Trend 21 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 12 days ago
80%
Bullish Trend 12 days ago
90%
Aroon
ODDS (%)
Bullish Trend 12 days ago
77%
Bearish Trend 12 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
GALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

GALT and

Correlation & Price change

A.I.dvisor indicates that over the last year, GALT has been loosely correlated with BCAB. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if GALT jumps, then BCAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GALT
1D Price
Change %
GALT100%
-1.53%
BCAB - GALT
37%
Loosely correlated
+2.18%
NVO - GALT
33%
Poorly correlated
-2.61%
RNAC - GALT
32%
Poorly correlated
+3.65%
SNPX - GALT
32%
Poorly correlated
-10.74%
AVIR - GALT
30%
Poorly correlated
-0.51%
More

PMN and

Correlation & Price change

A.I.dvisor indicates that over the last year, PMN has been loosely correlated with BBIO. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if PMN jumps, then BBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMN
1D Price
Change %
PMN100%
-10.13%
BBIO - PMN
40%
Loosely correlated
-2.54%
ABOS - PMN
29%
Poorly correlated
N/A
GALT - PMN
25%
Poorly correlated
-1.53%
NBY - PMN
25%
Poorly correlated
-0.58%
LIXT - PMN
25%
Poorly correlated
+0.75%
More